Telangana: Govt plans pharma university in state
Hyderabad: Telangana Government plans to establish a pharma university in the state in addition to the proposed Pharma City near here, Chief Minister K Chandrasekhar Rao said here.
"The purpose of the Pharma City is to bring all pharma industrial units at one place to overcome the pollution problem," a release from Chief Minister's office quoted him as saying.
Rao made the comments during a meeting with a two-member delegation of Ferring Pharma.
Ferring Pharmaceuticals has plans to invest USD 100-250 million for a plant in Telangana, the release said.
"A two-member delegation of Ferring Pharma, which has a global turnover and a full-fledged centre with manufacturing, R &D and supporting services, represented by its chairman Frederik Paulsen and CMD, India Dr Ashok Alate called on the Chief Minister with an investment proposal of 100-250 million USD," it said.
Stressing on the need to control pollution in production of bulk drugs, Rao said the government has undertaken a study as to how pharma production is managed in Scandinavia, European countries and United States to adopt the best practices.
"Chairman and CMD of Ferring Pharma told CM that theirs is an R&D Unit and they would like to concentrate in Telangana in future more. They also assured the CM that their unit will be of zero discharge as no pollution is allowed to go outside and will be treated within the premises," the release said.
Ferring Pharma has nine plants worldwide in countries like Argentina, China, Czech Republic, Denmark, Germany, Israel, Mexico, Scotland and Switzerland besides nine more R&D Units in other countries, according to the release.
They have two plants in India, in Maharashtra, and now would like to establish one in Telangana.
"The purpose of the Pharma City is to bring all pharma industrial units at one place to overcome the pollution problem," a release from Chief Minister's office quoted him as saying.
Rao made the comments during a meeting with a two-member delegation of Ferring Pharma.
Ferring Pharmaceuticals has plans to invest USD 100-250 million for a plant in Telangana, the release said.
"A two-member delegation of Ferring Pharma, which has a global turnover and a full-fledged centre with manufacturing, R &D and supporting services, represented by its chairman Frederik Paulsen and CMD, India Dr Ashok Alate called on the Chief Minister with an investment proposal of 100-250 million USD," it said.
Stressing on the need to control pollution in production of bulk drugs, Rao said the government has undertaken a study as to how pharma production is managed in Scandinavia, European countries and United States to adopt the best practices.
"Chairman and CMD of Ferring Pharma told CM that theirs is an R&D Unit and they would like to concentrate in Telangana in future more. They also assured the CM that their unit will be of zero discharge as no pollution is allowed to go outside and will be treated within the premises," the release said.
Ferring Pharma has nine plants worldwide in countries like Argentina, China, Czech Republic, Denmark, Germany, Israel, Mexico, Scotland and Switzerland besides nine more R&D Units in other countries, according to the release.
They have two plants in India, in Maharashtra, and now would like to establish one in Telangana.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.